Drug Profile
Research programme: antibacterials - Protein Design Labs
Alternative Names: Antibacterials research programme - Protein Design LabsLatest Information Update: 04 Oct 2001
Price :
$50
*
At a glance
- Originator PDL BioPharma
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 04 Oct 2001 Discontinued-Preclinical for Bacterial infections in USA (Unknown route)
- 22 Sep 1999 New profile
- 22 Sep 1999 Preclinical development for Bacterial infections in USA (Unknown route)